Huadong Medicine Co., Ltd
000963
Hisse Senetlerindeki Sıralama
#2704
Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in... Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in China, primarily focused on the creation, production, and distribution of a wide variety of medicinal products. Its extensive product catalog encompasses traditional Chinese patent medicines, immunosuppressive agents, endocrine treatments, digestive system remedies, cancer therapeutics, cardiovascular medications, and antibiotics. The company also supplies medical devices and offers solutions in the field of aesthetic medicine. Noteworthy product lines include gastrointestinal agents and Active Pharmaceutical Ingredients (APIs). Beyond its core pharmaceutical activities, Huadong Medicine is involved in the manufacturing and management of both traditional Chinese and Western raw medicines, prepared formulations, and health supplements. Its operations extend to the wholesale trade of Traditional Chinese Medicine (TCM) ingredients, prepared TCM decoction pieces, and various chemical preparations, complemented by warehousing and logistical services. A significant area of focus for the company is the research, development, manufacturing, and commercialization of aesthetic medicine products. Established in 1993, Huadong Medicine Co., Ltd maintains its corporate headquarters in Hangzhou, China.
Hisse Fiyatı
$3.89
Piyasa Değeri
$6.83B
Değişim (1 gün)
-2.22%
Değişim (1 yıl)
-30.58%
Ülke
CN
Ticaret Huadong Medicine Co., Ltd (000963)
Kategori
Healthcare
Huadong Medicine Co., Ltd (000963) için P/B oranı
October 2026 itibarıyla P/B oranı TTM: 1.79
Huadong Medicine Co., Ltd şirketinin en son mali raporları ve hisse fiyatına göre, mevcut P/B oranı (TTM) 1.79'dir. 2024 yılının sonunda şirketin P/B oranı 2.63 idi.
Huadong Medicine Co., Ltd için P/B oranı geçmişi 2001 - 2026 arası
Her yılın sonunda P/B oranı
| Yıl | P/B Oranı | Değiştir |
|---|---|---|
| 2026 (TTM) | 1.79 | -35.76% |
| 2025 | 2.79 | 5.99% |
| 2024 | 2.63 | -23.81% |
| 2023 | 3.45 | -21.72% |
| 2022 | 4.41 | 3.89% |
| 2021 | 4.24 | 33.47% |
| 2020 | 3.18 | -8.27% |
| 2019 | 3.47 | -1.23% |
| 2018 | 3.51 | -44.06% |
| 2017 | 6.27 | 31.37% |
| 2016 | 4.77 | -60.08% |
| 2015 | 11.96 | 18.56% |
| 2014 | 10.09 | 29.56% |
| 2013 | 7.79 | 5.26% |
| 2012 | 7.40 | -1.93% |
| 2011 | 7.54 | -38.83% |
| 2010 | 12.33 | 73.78% |
| 2009 | 7.10 | 14.69% |
| 2008 | 6.19 | -52.76% |
| 2007 | 13.10 | 341.31% |
| 2006 | 2.97 | 36.69% |
| 2005 | 2.17 | -9.09% |
| 2004 | 2.39 | -0.72% |
| 2003 | 2.41 | -4.52% |
| 2002 | 2.52 | -3.19% |
| 2001 | 2.60 | 0.00% |
Benzer şirketler veya rakipler için P/B oranı
| Şirket | P/B Oranı | P/B Oranı Farkı | Ülke |
|---|---|---|---|
| 1.9834 | 10.67% |
DE
|
|
| 2.1139 | 17.95% |
DE
|
|
| 1.3124 | -26.77% |
JP
|
|
| 6.3468 | 254.13% |
CH
|
|
| 5.0287 | 180.59% |
IN
|
